SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-07-061740
Filing Date
2007-03-22
Accepted
2007-03-22 16:47:55
Documents
10
Period of Report
2007-05-09
Effectiveness Date
2007-03-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 714272
2 GRAPHIC g29693001.jpg GRAPHIC 5550
3 GRAPHIC g29693amgen_letterhead.jpg GRAPHIC 21657
4 GRAPHIC g29693david_scott.jpg GRAPHIC 8476
5 GRAPHIC g29693g26e52.jpg GRAPHIC 39796
6 GRAPHIC g29693img001pc.jpg GRAPHIC 164569
7 GRAPHIC g29693img002pc.jpg GRAPHIC 153055
8 GRAPHIC g29693kevin_sharer.jpg GRAPHIC 6560
9 GRAPHIC g29693letterhead_002.jpg GRAPHIC 16940
10 GRAPHIC g29693recycle_symbol.jpg GRAPHIC 2556
  Complete submission text file 0001193125-07-061740.txt   1294750
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-12477 | Film No.: 07712393
SIC: 2836 Biological Products, (No Diagnostic Substances)